Skip to main content

AMONAFIDE (AS1413) IS UNAFFECTED BY MULTIDRUG RESISTANCE AND IS ASSOCIATED WITH A HIGH RESPONSE RATE IN PATIENTS WITH SECONDARY AML

Publication ,  Conference
Lundberg, S; Chau, M; Erba, HP; Dressel, AL; Acton, G; Capizzi, RL; Baer, MR
Published in: HAEMATOLOGICA
June 7, 2009

Duke Scholars

Published In

HAEMATOLOGICA

ISSN

0390-6078

Publication Date

June 7, 2009

Volume

94

Start / End Page

338 / 339

Publisher

FERRATA STORTI FOUNDATION

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lundberg, S., Chau, M., Erba, H. P., Dressel, A. L., Acton, G., Capizzi, R. L., & Baer, M. R. (2009). AMONAFIDE (AS1413) IS UNAFFECTED BY MULTIDRUG RESISTANCE AND IS ASSOCIATED WITH A HIGH RESPONSE RATE IN PATIENTS WITH SECONDARY AML. In HAEMATOLOGICA (Vol. 94, pp. 338–339). FERRATA STORTI FOUNDATION.
Lundberg, S., M. Chau, H. P. Erba, A. L. Dressel, G. Acton, R. L. Capizzi, and M. R. Baer. “AMONAFIDE (AS1413) IS UNAFFECTED BY MULTIDRUG RESISTANCE AND IS ASSOCIATED WITH A HIGH RESPONSE RATE IN PATIENTS WITH SECONDARY AML.” In HAEMATOLOGICA, 94:338–39. FERRATA STORTI FOUNDATION, 2009.
Lundberg S, Chau M, Erba HP, Dressel AL, Acton G, Capizzi RL, et al. AMONAFIDE (AS1413) IS UNAFFECTED BY MULTIDRUG RESISTANCE AND IS ASSOCIATED WITH A HIGH RESPONSE RATE IN PATIENTS WITH SECONDARY AML. In: HAEMATOLOGICA. FERRATA STORTI FOUNDATION; 2009. p. 338–9.
Lundberg, S., et al. “AMONAFIDE (AS1413) IS UNAFFECTED BY MULTIDRUG RESISTANCE AND IS ASSOCIATED WITH A HIGH RESPONSE RATE IN PATIENTS WITH SECONDARY AML.” HAEMATOLOGICA, vol. 94, FERRATA STORTI FOUNDATION, 2009, pp. 338–39.
Lundberg S, Chau M, Erba HP, Dressel AL, Acton G, Capizzi RL, Baer MR. AMONAFIDE (AS1413) IS UNAFFECTED BY MULTIDRUG RESISTANCE AND IS ASSOCIATED WITH A HIGH RESPONSE RATE IN PATIENTS WITH SECONDARY AML. HAEMATOLOGICA. FERRATA STORTI FOUNDATION; 2009. p. 338–339.

Published In

HAEMATOLOGICA

ISSN

0390-6078

Publication Date

June 7, 2009

Volume

94

Start / End Page

338 / 339

Publisher

FERRATA STORTI FOUNDATION

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology